Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group (Q42686887)
Jump to navigation
Jump to search
scientific article published on September 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group |
scientific article published on September 1998 |
Statements
1 reference
Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group (English)
1 reference
Anzueto A
1 reference
Niederman MS
1 reference
Tillotson GS
1 reference
1 September 1998
1 reference
1 reference
20
1 reference
5
1 reference
885-900
1 reference
Identifiers
1 reference
1 reference